Mediclinic International plc, commonly known as Mediclinic, is a leading private healthcare group headquartered in South Africa (ZA). Established in 1983, the company operates a network of hospitals and clinics across Southern Africa, the Middle East, and Switzerland, providing high-quality medical services.
Specialising in acute care, rehabilitation, and outpatient services, Mediclinic is renowned for its commitment to patient safety and clinical excellence. The group has achieved significant milestones, including the integration of advanced technology and a focus on specialised medical fields, which sets it apart in the competitive healthcare landscape.
With a strong market position, Mediclinic has been recognised for its innovative healthcare solutions and exceptional patient care, making it a trusted name in the industry.
-1 vs industry average
Mediclinic’s score of 21 is lower than 49% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Mediclinic?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Mediclinic's reported carbon emissions
Mediclinic, headquartered in ZA, is committed to achieving carbon neutrality by 2030. This ambitious target encompasses all scopes of emissions. In terms of reported emissions, for the fiscal year 2023, Mediclinic reported a total of approximately 299.9 billion kg CO2e, comprising 117.1 billion kg CO2e from Scope 3 emissions and 182.9 billion kg CO2e from Scope 1 and 2 emissions. For the fiscal year 2022, the total emissions were approximately 278.0 billion kg CO2e, with Scope 3 emissions accounting for about 72.8 billion kg CO2e and Scope 1 and 2 emissions totalling approximately 205.3 billion kg CO2e. In 2021, Mediclinic reported approximately 271.5 billion kg CO2e in total emissions, broken down into 59.6 billion kg CO2e for Scope 3 and 212.0 billion kg CO2e for Scope 1 and 2. Previously, in 2020, total emissions were approximately 280.3 billion kg CO2e, with Scope 3 at about 54.3 billion kg CO2e and Scope 1 and 2 at approximately 226.0 billion kg CO2e. For the fiscal year 2019, total emissions amounted to approximately 298.9 billion kg CO2e, with Scope 3 emissions at about 59.0 billion kg CO2e and Scope 1 and 2 emissions at approximately 240.0 billion kg CO2e. In 2018, Mediclinic reported Scope 1 and 2 emissions totalling approximately 214.5 billion kg CO2e. Data for Scope 3 emissions was not disclosed for this year. For 2017, Scope 1 emissions were approximately 6.3 million kg CO2e, and purchased electricity (Scope 2) was about 837,000 kg CO2e. Scope 3 data was not disclosed. In 2016, Scope 1 emissions were approximately 7.3 million kg CO2e, and purchased electricity (Scope 2) was about 389,000 kg CO2e. Scope 3 data was not disclosed. In 2015, Scope 1 emissions were approximately 6.7 million kg CO2e, and purchased electricity (Scope 2) was about 389,000 kg CO2e. Scope 3 data was not disclosed. For 2014, Scope 1 emissions were approximately 7.2 million kg CO2e, and purchased electricity (Scope 2) was about 419,000 kg CO2e. Scope 3 data was not disclosed. In 2013, Scope 1 emissions were approximately 7.3 million kg CO2e, and purchased electricity (Scope 2) was about 365,000 kg CO2e. Scope 3 data was not disclosed. For 2012, total emissions were approximately 188.8 million kg CO2e, with Scope 1 at about 19.5 million kg CO2e and Scope 2 (purchased electricity) at approximately 152.9 million kg CO2e. Scope 3 data was not disclosed. In 2011, total emissions were approximately 190.7 million kg CO2e, with Scope 1 at about 19.7 million kg CO2e and Scope 2 (purchased electricity) at approximately 154.3 million kg CO2e. Scope 3 data was not disclosed. Mediclinic's commitment to becoming carbon neutral by 2030 is a key aspect of its sustainability strategy. The company has also set targets for 2030 to be carbon neutral and send no waste to landfill.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Mediclinic’s Climate Goals (2030 & 2050)
1 goal2030
BECOMING CARBON NEUTRAL BY 2030
BECOMING CARBON NEUTRAL BY 2030
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project